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Abstract
This chapter will review the rationale for and the need for pulmonary rehabilitation in 
patients with Chronic Obstructive Pulmonary Disease (COPD). Its clinical effectiveness 
will be considered, including the evidence supporting a role for rehabilitation in improv-
ing exercise tolerance in COPD as measured. While the influence of pulmonary reha-
bilitation on dyspnoea, exercise tolerance and quality-of-life is clear, evidence for the 
benefits of rehabilitation on reducing healthcare utilisation such as admission to hospital 
or attendance at out-of-hours services is limited. The chapter will provide guidance on 
the setting up of a pulmonary rehabilitation programme and clinical staff required and 
the suitability of patients to enter such programmes will be outlined. There will be dis-
cussion on the key components of a programme including education, nutritional advice 
and the management of dyspnoea. Exercise is the central component of pulmonary reha-
bilitation. Assessment of the patient and prescription of an exercise programme will be 
outlined as will assessing a patient’s improvement. One key goal of pulmonary rehabili-
tation is ongoing lifestyle modification to encourage patients to undertake a more active 
lifestyle in the future. Ways of activating patients to do this will be discussed and the 
evidence for the use of telehealth in this area will be reviewed.
Keywords: pulmonary rehabilitation, COPD, exercise, physical activity
1. Introduction
COPD is a systemic disease associated with extra pulmonary effects such as osteopaenia, 
muscle wasting, cardiovascular disease and depression [1]. The symptoms of COPD make 
engagement in physical activity unpleasant. Air trapping and hyperinflation of the lungs 
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cause increased breathlessness due to the resultant inefficient breathing. The breathlessness 
itself provokes anxiety, which in turn leads to further breathlessness, exacerbations of COPD 
and episodes of panic. Due to this, activities that involve physical exertion are avoided, lead-
ing to muscle deconditioning and a further reduced capacity to engage in physical activity. 
Pulmonary rehabilitation improves symptoms, quality of life and health-care utilisation in 
patients with COPD [1, 2].
Pulmonary rehabilitation is defined as “an interdisciplinary programme of care for 
patients with chronic respiratory impairment that is individually tailored and designed 
to optimise each patient’s physical and social performance and autonomy. Programmes 
comprise individualised exercise programmes and education” [3]. Physical inactivity is 
a key predictor of mortality in COPD and consequently all major guidelines highlight 
the importance of exercise in the treatment and management of COPD. There is now 
high quality evidence for improved exercise capacity, health-related quality of life and 
decreased breathlessness, fatigue and health-care utilisation following pulmonary reha-
bilitation [1].
Pulmonary rehabilitation is focussed on an interdisciplinary and holistic approach to the 
management of COPD, emphasising behavioural change as a key component. It fits very 
well with the concept of integrated care, with its cornerstone being individually tailored 
exercise training. Patient assessment, education, psychosocial support and nutritional 
counselling are also included in the standard pulmonary rehabilitation programme. 
Overall, the focus of a pulmonary rehabilitation programme is to alleviate the physiologi-
cal effects of the disease process and decrease the psychosocial effects of the illness on the 
individual.
2. Historical development
The effects of exercise in patients with chronic respiratory diseases have been a subject for 
study for some time. By the middle of the 20th century, accepted wisdom was that dyspnoea 
on exertion should be avoided [4]. Dr. Alvan Barach was the first to offer a contrary opinion 
in the 1950s, with his advice to “remember to cure the patient as well as the disease”. Thomas 
L. Petty was the first to establish an out-patient programme of pulmonary rehabilitation in 
the 1960s, despite the conventional wisdom of not exerting patients with respiratory limi-
tations. This programme included individualised instruction, bronchial hygiene, breathing 
retraining, physical reconditioning and individualised pharmacologic therapy. Rehabilitation 
programmes were set up throughout the USA, and Petty noted improved exercise tolerance, 
reduced hospitalisations and a return to gainful employment in the majority of his patients 
[4]. Subsequently, in the 1980s a view became prevalent that as exercise conditioning did not 
improve lung function, pulmonary rehabilitation was unlikely to provide physiological ben-
efit to patients. It was felt that if physiological benefit was not demonstrated, the programme 
design was not particularly important. Finally, in the 1990s, physiologic benefit was proven 
by using exercise at a higher intensity and the concept of pulmonary rehabilitation was rein-
vigorated [4, 5].
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3. Rationale for pulmonary rehabilitation
Pulmonary rehabilitation is designed to reduce the symptoms of COPD, improve health 
related quality of life (HRQoL), improve and re-establish functional ability, enhance partici-
pation in everyday life and promote patient autonomy. The exercise component of pulmo-
nary rehabilitation increases inspiratory volume and reduces dynamic hyperinflation, both 
of which reduce dyspnoea when a person is performing tasks. Exercise also increases muscle 
function, which delays fatigue and results in increased exercise tolerance. The educational 
component focuses on self-management and behaviour change. Providing information and 
knowledge, skills such as goal setting, problem solving and decision making, along with 
action plans to better recognise and manage their disease are all integral parts of the pro-
gramme. Modifying nutritional intake and smoking patterns, medication adherence and 
utilising effective energy-saving strategies and breathing techniques are part of the educa-
tion component [1].
The exercise capacity of patients with COPD is often impaired and limited by dyspnoea. 
The reasons for this are complex and multifactorial, including defective gas exchange, 
dynamic hyperinflation, peripheral muscle dysfunction, respiratory muscle dysfunction, 
the effects of physical deconditioning, the presence of co-morbidities and the natural age-
related decline in exercise capacity [6]. Physical exercise in pulmonary rehabilitation is 
the best method of improving muscle function and skeletal muscle adaption in patients 
with COPD [5, 7–10]. The benefits pulmonary rehabilitation produces are explained 
by improvements in muscle function and the oxidative capacity and efficiency of skel-
etal muscles, despite the absence of any changes in lung function [11, 12]. Other related 
improvements include increased motivation, improved mood and improved cardiovascu-
lar functioning, which result in ongoing participation in exercise beyond the rehabilitation 
programme [13].
Even those patients with severe chronic respiratory disease can often sustain the necessary 
training intensity and duration for skeletal muscle adaptation. Skeletal muscle adaptation fol-
lowing exercise training leads to gains in exercise capacity despite the absence of changes in 
lung function. In addition, the improved oxidative capacity and efficiency of the skeletal mus-
cles leads to a reduced ventilator requirement for a given submaximal work rate. This could 
reduce dynamic hyperinflation, adding to the reduction in exertional dyspnoea [6]. Medical 
therapy should be optimised prior to exercise training beginning and a patient assessment is 
required prior to beginning an exercise programme.
4. The clinical effectiveness of pulmonary rehabilitation
4.1. Physiological
One of the first studies to show an improvement in exercise tolerance following exercise 
training in COPD was Casaburi et al. in 1991 [14]. They showed a statistically significant 
improvement in exercise tolerance and reduced blood lactate and ventilatory requirement 
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post exercise. These findings have been supported by others [5] and a Cochrane review in 
2009 [2] showed a statistically significant improvement in exercise capacity in people who 
underwent a pulmonary rehabilitation programme. Results of a further Cochrane review in 
2015 strongly supported the benefits of pulmonary rehabilitation [1]. They found clinically 
and statistically significant improvements in important domains of health-related quality of 
life, including dyspnoea, fatigue, emotional function and mastery, as well as the 6 minute 
walk test: a measure of functional exercise [1]. Also noted was a small but statistically signifi-
cant improvement in physical activity levels. Physical activity has become more important 
in COPD management as it has been shown that inactivity is linked with reduced survival, 
poorer quality of life and increased healthcare utilisation [15].
4.2. Quality of life
The benefits of pulmonary rehabilitation on dyspnoea and health status have been supported 
by a Cochrane review [1]. The Chronic Respiratory Questionnaire was used in a number of 
studies and showed an improvement in dyspnoea that was statistically significant and clini-
cally relevant. Improvement was also noted in the other CRQ domains of fatigue, emotional 
function and patient’s sense of control. The St. Georges Respiratory Questionnaire Scores 
were also subject to a meta-analysis in the same Cochrane review and found to show signifi-
cant improvement following pulmonary rehabilitation [16].
4.3. Reduction of healthcare utilisation
Several studies have investigated whether pulmonary rehabilitation leads to a decrease in the 
number of caregiver or physician visits, hospital days, and medication use [3, 6]. In general, 
some benefit is shown in this important area. Several randomised studies comparing pulmo-
nary rehabilitation with usual care found a trend towards reduced hospital admissions and 
hospital days. Studies comparing healthcare use before and after pulmonary rehabilitation 
show that pulmonary rehabilitation significantly reduced emergency room visits and physi-
cian visits [3, 6].
4.4. Psychosocial
In a Cochrane review published in 2015, participants allocated to rehabilitation had signifi-
cantly greater changes in HRQoL [17]. A Cochrane review in 2009 had previously shown 
moderate to large effects of rehabilitation on health-related quality of life and exercise 
capacity [2].
4.5. Self-efficacy
Self-efficacy refers to the level of belief someone has in their ability to complete a chosen task 
or goal. Overall, self-efficacy scores improve with pulmonary rehabilitation [1].
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4.6. Survival
There is limited evidence for increased survival to date, however only one randomised con-
trolled trial has looked at survival: the control group received education and the interven-
tion group received rehabilitation and education. The study was unlikely to be powered to 
detect mortality [18]. A prospective observational study of 1218 patients showed no mortal-
ity benefit from pulmonary rehabilitation [19]; however, another study did show improved 
mortality in patients where exercise capacity and dyspnoea improved after rehabilitation 
only [9].
4.7. Nutrition
In an underweight population, some small weight gain was noted following exercise train-
ing; however, in general the effect of pulmonary rehabilitation on nutritional status does not 
appear to be significant. Nutritional outcomes at the start of a rehabilitation programme do 
not affect outcomes such as exercise capacity or health status [6].
5. Setting up a pulmonary rehabilitation Programme
5.1. Duration
There remains no consensus internationally on the optimum duration of a pulmonary reha-
bilitation programme. However, pulmonary rehabilitation programmes of 6–12 weeks are 
recommended and demonstrate a significant benefit in health status, dyspnoea and exercise 
in patients with chronic respiratory diseases limited by breathlessness. An attendance at a 
minimum of 12 exercise sessions is recommended to successfully complete the programme. 
Programmes of less than 6 weeks have been shown to provide some benefits in health sta-
tus and exercise capacity in individuals with COPD; however, these programmes should be 
individualised and measures of benefit should be in place prior to the patient concluding the 
programme. The ongoing benefits of a pulmonary rehabilitation programme of longer than 
3 months duration has been shown, including changes in daily physical activity levels, but the 
cost benefit of these remains unclear [3, 6, 20–22].
5.2. Frequency
The recommended frequency of exercise classes also differs internationally. The general 
consensus supports a minimum of two supervised exercise sessions per week, and either 
a third supervised session or formalised unsupervised session depending on the resources 
available. This is in contrast with the WHO recommendation of 5 sessions of 30 minutes 
exercise per week. However, to date the key improvement outcomes in pulmonary reha-
bilitation are based on at least two supervised sessions per week. Pulmonary rehabilitation 
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programmes should therefore encompass a minimum of twice weekly supervised exercise 
sessions, a third session of prescribed unsupervised exercise and encouragement of regular 
physical activity for 30 minutes five days per week in line with standard healthy living 
advice [3, 6, 20–22].
5.3. Staffing
There is no consensus on staffing levels for a pulmonary rehabilitation programme. The staff-
ing of the programmes varies globally, with physical therapists coordinating programmes in 
Australia, South America and Europe, while respiratory therapists coordinate programmes in 
the United States. There is no one best staffing structure. Optimal staff-patient ratios also dif-
fer: the American Association of Cardiovascular and Pulmonary Rehabilitation recommends 
ratios of 1:4 for exercise training, 1:8 for educational sessions and 1:1 for complex patients; 
the British Thoracic Society recommends ratios of 1:8 for exercise training and 1:16 for edu-
cational sessions. These ratios are not evidence based and are designed based on experience 
and opinion [3, 6, 20–22].
It is recommended and accepted that for patients to gain optimum benefit from a pulmonary 
rehabilitation programme, a multidisciplinary approach should be taken [13, 23]. Availability 
of resources and staff will dictate the level of input the Multidisciplinary team will have but 
each member plays an important role in the rehabilitation programme:
• Respiratory physician: medical assessment; pharmacological management; referral; screen-
ing for oxygen and oxygen prescription.
• Physiotherapist: exercise testing, prescription and training; musculoskeletal assessment, 
treatment and advice; airway clearance education; strategies for the management of dys-
pnoea; inspiratory muscle training; assessment for ambulatory oxygen requirements.
• Respiratory nurse: Disease specific education; development of action plans; inhaler tech-
nique training.
• Dietician: Nutritional assessment and advice.
• Occupational therapist: Assessment and modification of home environment; energy conser-
vation advice.
• Pharmacist: advice and education on respiratory education and inhaler use.
• Social worker: information and access to support services.
• Psychologist: psychosocial assessment and treatment for conditions including panic, anxiety 
and depression.
5.4. Rolling or cohort programme
Deciding on whether to administer a rolling or a cohort programme is dependent on local 
considerations, as there is no high-quality evidence to suggest the benefit of one over the 
other. The characteristics of a rolling and a cohort programme are outlined in Table 1 [3]:
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5.5. Selection criteria for pulmonary rehabilitation programmes
Any person with a chronic lung condition who continues to be limited by breathlessness despite 
optimal medical management should be considered for a pulmonary rehabilitation programme 
[22]. Improvements following a pulmonary rehabilitation programme have been shown in 
patients with COPD irrespective of their age or gender [24–26] level of functional impairment 
[27–29] or disease severity [30, 31]. By promoting self-efficacy and behaviour change, improv-
ing exercise tolerance and physical activity and reducing exacerbations, pulmonary rehabilita-
tion at an earlier stage of disease has the potential to markedly change the course of the disease 
[6]. Frequent reasons for referral to a pulmonary rehabilitation programme include:
• Dyspnoea/fatigue and chronic respiratory symptoms.
• Impaired health-related quality of life.
• Decreased functional status.
• Difficulty performing activities of daily living.
• Increased use of medical resources (e.g., frequent exacerbations, hospitalizations, emer-
gency room visits).
• One of the primary indicators for referral to pulmonary rehabilitation is based on the modi-
fied Medical Research Council Breathlessness (mMRC) score (see Table 2) [3]. This scale 
Rolling Cohort
Nature of programme Continual cycle of sessions, where patients 
join when there is a space available and 
leave after completing the programme of 
sessions
All patients start and finish the 
programme at the same time
Waiting list Patients enter the programme when a 
space arises, permits fast track access, 
potentially allows better capacity
An accumulative number of patients 
wait to start the programme, the 
waiting list may be distorted
Rehabilitation delivered at 
different locations by the same 
team
Not possible as the programme always 
runs in the same venue
Suitable
Education programme The order of the talk is individual and 
governed by the point of entry
Can ‘flow’ in a logical order
Group dynamics A new patient may be the sole new 
participant which may be a beneficial or a 
challenge
Patients all start together which 
permits group leaning of lifestyle 
changes
Assessments Must perform pre and post assessments in 
parallel to the course
Dedicated assessment slots can be 
programmed for all subjects pre and 
post rehabilitation
Duration of programme Allows lengthening the programme or 
early graduation as required
Fixed length for each programme
Table 1. Characteristics of Rolling and  Cohort programmes.
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measures perceived respiratory disability, and allows patients to indicate the extent to 
which their breathlessness impacts their mobility. It is a 0–4 grade scale used to establish 
levels of perceived breathlessness [3, 6].
There is very strong evidence that patients with an mMRC dyspnoea score of 2–4 who are 
functionally limited by breathlessness should be referred for pulmonary rehabilitation. 
However, patients with an mMRC dyspnoea score of 1 who are functionally limited by 
breathlessness should also be referred for pulmonary rehabilitation. Patients with COPD who 
have an mMRC score of 4 but who are able to attend an outpatient pulmonary rehabilitation 
programme achieve similar benefits from the programme as those with a lower breathless-
ness score [28].
5.6. Exclusion criteria
The exclusion criteria for enrolment into a pulmonary rehabilitation programme are mini-
mal, and in some cases participation in the programme by a patient can be facilitated by the 
attendance and support of a carer or relative. However, general exclusion guidelines would 
include [3, 6]:
• Patients with unstable cardiovascular disease or mobility problems which make exercising 
safely impossible (for example, severe arthritis, severe peripheral vascular disease, severe 
orthopaedic conditions).
• Patients with significant psychiatric or cognitive impairment who are unable to follow 
simple instructions safely in a group setting.
• Any further excluding factors are based on the assessor’s own objective judgement or with 
a discussion with the referring physician, for example, a perceived lack of motivation to 
participate in the programme.
5.7. Referral process
Once a patient has been deemed suitable to attend a pulmonary rehabilitation programme 
by the healthcare professional, the referral should be used as an opportunity to educate the 
patient about the benefits of the programme, to explore their understanding of the programme 
Grade Degree of breathlessness related to activities
0 Not troubled by breathless except on strenuous exercise
1 Short of breath when hurrying or walking up a slight hill
2 Walks slower than contemporaries on level ground because of breathlessness or has to stop for breath when 
walking at own pace
3 Stops for breath after walking 100 metres or after a few minutes on level ground
4 Too breathless to leave the house, or breathless when dressing or undressing
Table 2. The modified Medical Research Council Breathlessness (mMRC) score.
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and to address the patients’ concerns [3]. The programme should be presented to the patient 
as a core treatment for the management of their condition as opposed to an optional adjunct. 
Patients should be referred to the programme under the care of a respiratory physician, who 
should be available to the staff co-ordinating the programme to discuss any medical problems 
which may arise during the programme and to ensure that potential participants have been 
medically assessed for suitability for the programme and that their pharmacological manage-
ment has been optimised [22].
5.8. Pulmonary rehabilitation post exacerbations of COPD
Exacerbations of COPD result in increased mortality and healthcare use, worsening symptoms 
and health-related quality of life, as well as impaired exercise capacity, reduced skeletal muscle 
function of the lower limbs and reduced physical activity levels [3, 6]. Studies have therefore 
been conducted to explore the merits and the safety of ‘early’ pulmonary rehabilitation both 
during a hospital admission and within 1 month of hospital discharge for an acute exacerba-
tion of COPD. It is now known that early pulmonary rehabilitation post exacerbation [2]:
• Is not associated with any adverse events or increased mortality
• Reduces risk of hospital readmissions
• Improves health related quality of life
• Improves exercise capacity
It is therefore recommended unequivocally that patients with COPD who are hospitalised 
for an acute exacerbation should be referred for pulmonary rehabilitation at discharge, and 
should be enrolled into the pulmonary rehabilitation programme within 1 month of leaving 
the hospital.
6. Patient assessment
The initial assessment for the programme is an opportunity to outline a detailed description 
of the programme to the patient, to assess for co-morbidities, risk factors and contraindica-
tions for the programme, and to consider any appropriate onward referrals to maximise the 
benefit the patient will receive from the programme [3]. The essential information required 
for pulmonary rehabilitation includes:
• Known communication/language barriers.
• Current activity levels.
• Respiratory diagnosis: spirometry for those with COPD.
• Height, weight, BP and oxygen saturations at rest are desirable.
• Modified Medical Research Council breathlessness score.
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• Smoking status (for those who continue to smoke, document details of previous attempts 
to quit; recent quitters may require support and/or counselling).
• Therapies: current list of medication.
• Use of oxygen: long-term oxygen therapy, short-burst oxygen therapy, ambulatory; oxy-
gen saturations, use of domiciliary Positive Pressure Ventilation.
• Significant and relevant comorbidities (which may affect their ability to participate in the 
exercise programme or education sessions, including adequacy of literacy and vision).
• Transport needs: if applicable to that rehabilitation provider.
• Health care utilisation: including number of hospital admissions and length of stay in the 
previous 12 months.
6.1. Specific situations at assessment
When deciding on a patient’s suitability for pulmonary rehabilitation, there are certain 
groups of patient characteristics which need further consideration during assessment for the 
programme including [3]:
6.1.1. Smoking status
There is currently no evidence that smokers benefit any less from pulmonary rehabilitation 
than non-smokers, and the rehabilitation programme can be an ideal opportunity to support 
and facilitate these patients in smoking cessation. Smokers should be offered smoking cessa-
tion advice and should be referred to smoking cessation programmes.
6.1.2. Chronic respiratory failure
Patients with chronic respiratory failure (PaO2 < 8 kPa, PO2 > 6 kPa or both) gain much ben-
efit from pulmonary rehabilitation and should not be excluded from the programme for this 
reason alone. The use of oxygen and non-invasive ventilation for these patients during the 
programme should be discussed with the referring physician, and the safety of the patient 
with consideration to the skill mix of the staff in the programme and the programme setting 
should also be considered when accepting these patients onto the programme.
6.1.3. Cardiovascular disease
From a safety perspective, patients with unstable cardiovascular disease (e.g. unstable angina, 
unstable arrhythmias) should not commence a pulmonary rehabilitation programme until 
their cardiac condition is stabilised. However, patients with stable cardiovascular disease as 
well as a chronic respiratory disease do benefit from the programme, and should be referred 
if pulmonary rehabilitation is indicated. Patients with aortic aneurysms <5.5 cm can partici-
pate safely in moderate intensity aerobic exercise training as long as their blood pressure is 
monitored and controlled.
COPD - An Update in Pathogenesis and Clinical Management112
6.1.4. Anxiety and depression
Patients with symptoms of anxiety and depression also benefit from the pulmonary reha-
bilitation programme, and should not be excluded from referral to the programme. The pul-
monary rehabilitation programme allows an opportunity to detect these conditions and to 
consider onward referral for optimal management.
6.1.5. Obese subjects
Pulmonary rehabilitation may be an ideal setting in which to address the needs of obese 
patients with associated respiratory symptoms, including exercise training, nutritional edu-
cation, psychological support and onward referral to specialists as required. Obese patients 
should not be excluded from the pulmonary rehabilitation programme; however, assess-
ments for other cardiac and pulmonary comorbidities may need to be considered prior to 
commencing the pulmonary rehabilitation programme. Weight limits of equipment should be 
considered, low impact exercises may be more appropriate and specialised equipment may 
be required to accommodate these patients [6].
6.1.6. Co-morbidities
COPD is commonly associated with other medical co-morbidities, which may result from 
the common risk factors for COPD such as smoking as well as systemic inflammation. These 
can further impact on the patient’s management, and can include cardiovascular disease 
(arrhythmias, congestive heart failure, hypertension, and coronary disease), metabolic condi-
tions (diabetes mellitus, osteoarthritis, and hyperlipidaemia), infections, lung cancer, obstruc-
tive sleep apnoea, cognitive dysfunction, depression or anxiety. These co-morbidities must 
be considered in the assessment and management of COPD patients enrolled in a pulmonary 
rehabilitation programme, as early intervention may influence the course and prognosis of 
the disease and can have a beneficial effect on both COPD and the relevant co-morbidity. 
Pulmonary rehabilitation is very important for patients with COPD and co-morbidities as 
physical activity is well documented to not only benefit COPD but also many other chronic 
conditions including obesity, diabetes, cardiovascular disease, musculoskeletal disease and 
peripheral vascular disease [32–36].
The presence of co-morbidities does not preclude pulmonary rehabilitation in patients 
with COPD but they should be considered thoroughly when monitoring and prescribing 
exercise to allow these individuals to exercise safely. For patients with cardiac conditions, 
the need for pre-rehabilitation investigations (for example, echocardiography or stress 
testing) should be discussed with the referring physician to define safe exercise param-
eters. Anaemia, orthopaedic and neurological issues require further consideration of a 
safe exercise plan and the need for specialised equipment. The patient may also require 
further onward referrals (for example, dual energy X-ray absorptiometry (DEXA) scan, 
psychological review, and nutritional review) based on observations during the exercise 
programme.




Prior to commencing the rehabilitation programme, an exercise assessment is essential to [6]:
• Ensure the patient is safe to participate
• Rule out cardiovascular morbidities
• Assess baseline capacity
• Individualise exercise prescription
• Assess for the need for supplementary oxygen
• Define the factors contributing to exercise limitation
• Evaluate the effectiveness of the intervention
Exercise tests can include field walking tests, or laboratory cycle ergometer or treadmill tests. 
Field walking tests are most commonly used, and are considered more reflective of daily liv-
ing; they are low cost and are convenient in most settings. These include the 6-minute walk 
test (6MWT) and the incremental shuttle walk test (ISWT). The 6MWT is a valid, reliable 
and reproducible self-paced walk test once the established, recommended and standardised 
protocol is used. Performed over a minimum of 30 metres, patients are asked to walk as far 
as possible in 6 minutes along a flat corridor [37]. The ISWT is a symptom limited maximal 
exercise capacity, externally paced walk test performed over a 10-metre course. It is also valid 
and reliable. The walk speed continues until the participant can no longer continue, with a 
maximum duration of 20 minutes. The endurance shuttle walks test (ESWT) is a constant 
walking speed test performed at a set speed based on the ISWT [6].
The choice of test is usually decided based on objectives, time, cost and availability.
7. Exercise training in pulmonary rehabilitation
Lower limb weakness is commonly seen in patients with COPD, and is a poor prognostic 
indicator [12]. The exercise component of pulmonary rehabilitation therefore should primar-
ily be delivered reflecting aerobic exercise and on lower limb endurance and resistance train-
ing. The general principles of exercise in COPD are no different than in exercising a healthy 
population: it must reflect the individuals own capacity, progress as improvement occurs 
and exceed normal loads encountered in daily life to improve aerobic capacity and muscle 
strength.
7.1. Aerobic/endurance training
A target intensity of 60% peak work rate, aiming for an accumulative time of 30–60 min-
utes of aerobic training per session is recommended, with 30 minutes of continuous aerobic 
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activity [3]. However, both interval and continuous training have been shown to be effective 
in patients with COPD, and should be selected based on both therapist and patient prefer-
ence. Endurance exercise, most commonly delivered in the form of walking (treadmill or 
ground walking) or cycling, three to five times per week at a Borg dyspnoea or fatigue score 
of 4–6 (moderate to severe) is the recommended target training intensity [6].
7.2. Resistance training of the lower limbs
Resistance training of all major muscle groups, but particularly the quadriceps, should also 
be incorporated, not only for the improvements that are well documented for COPD symp-
toms, but also to reduce falls and to improve or maintain bone mineral density [6]. Resistance 
training should aim for 2–4 sets of 10–15 repetitions of each exercise, on 2–3 days of the week. 
The selected weight should be individualised for each patient, aiming for a prescribed weight 
of 60–70% of 1 repetition maximum for each individual patient. The weight should only 
have progressed once all sets can be completed with the selected weight [6]. Based on local 
resources, weight machines, elastic bands or free weights are all acceptable forms of resistance 
training.
7.3. Resistance training of the upper limbs
While it is suggested that upper limb training can improve upper limb function in patients 
with COPD, the optimal prescription of this training remains unclear, as do the improve-
ments gained in broader outcomes for COPD patients. However, upper limb training may 
be incorporated based on individual needs to improve functional living. It could be assumed 
that starting loads and progression may follow the same prescription as for lower limb train-
ing [20].
7.4. Flexibility training
While minimal research has been done on flexibility training as part of the pulmonary rehabil-
itation programme or the optimal duration and intensity of stretching exercises, flexibility of 
the major upper and lower limb muscle groups on 2–3 days a week can be recommended [38]. 
Also, improved thoracic mobility and posture may improve vital capacity in COPD patients, 
and should be assessed and addressed in all COPD patients [6].
7.5. Generic vs. individualised exercise programmes
Generic exercise training is recommended for the pulmonary rehabilitation classes: all patients 
in the class should do all the same exercises as opposed to an individualised exercise pro-
gramme for each patient. However, the prescription of exercise should be individualised to 
each patient to ensure the correct intensity for that patient. Goal setting should be addressed 
with each patient on the initial assessment to address any hurdles to exercise and to further 
address each patient’s specific needs [3].
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8. Education in pulmonary rehabilitation
Education on COPD and its management to both patient and family is an integral component 
of pulmonary rehabilitation programmes. Several studies show that patients instructed about 
the nature of their disease and the implications of therapy can better understand, recognise, 
and treat the symptoms of their disease [39]. The educational component acts as a support to 
lifestyle and behavioural change, and assists in the development of self-management skills. 
Patients are empowered to actively participate in their own healthcare, which can promote 
adherence to therapy and self-efficacy (i.e., the confidence in successfully managing one’s 
health). The educational needs of each patient should be individualised and identified at the 
initial assessment and reassessed over the course of the programme. The style of teaching 
used in pulmonary rehabilitation is changing from traditional didactic lectures to a collabora-
tive self-management approach, which may be more effective [6]. Education should run in 
conjunction with an exercise programme and should cover relevant topics associated with 
chronic lung disease. Different aspects should be delivered by different healthcare profession-
als involved in the programme, with the relevant expertise in that area.
Self-management includes core generic strategies, such as goal setting, problem solving, 
decision making, adherence to medication, maintaining regular exercise, nutritional advice, 
breathing techniques, bronchial hygiene and smoking cessation [40, 41]. Behavioural change 
strategies including the prevention, early recognition and treatment of exacerbations and 
advanced care directives are additional core educational issues incorporated in collabora-
tive self-management programmes. The development of a patient-specific, collaborative 
self-management plan for COPD exacerbations including the recognition of symptoms, a 
personalised action plan and communication with a healthcare provider has been shown to 
be beneficial [41, 42].
8.1. Breathing strategies
Breathing strategies encompasses a range of breathing techniques, including active expira-
tion, pursed lip breathing, diaphragmatic breathing, adapting certain body positions and co-
ordinating paced breathing with activities. The aim of these techniques is to improve regional 
ventilation, gas exchange, respiratory muscle function, dyspnoea, exercise tolerance and 
quality of life [43].
The breathing strategies are tailored to the individual, with patients adopting the technique 
most effective in reducing symptoms [44].
8.2. Bronchial hygiene techniques
Excessive airway secretions secondary to mucus hypersecretion and impaired mucocili-
ary clearance are distinctive features for some patients. Chest physiotherapy is used to aid 
removal of airway secretions, which involves teaching on importance of daily clearance and 
training in drainage techniques [45].
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8.3. Smoking cessation
In approximately 90% of cases of COPD, cigarette smoking is the direct cause. The single most 
important intervention to retard the progression of air-flow limitation and improve survival 
is smoking cessation. For many patients smoking cessation may be difficult due to strong 
physiologic and psychological dependence. Long-term quit success rates of up to 25% can be 
achieved when sufficient reserves and time are dedicated to smoking cessation programmes 
[46]. The rehabilitation programme provides a forum for education and continued reinforce-
ment, on risks of continued smoking, advice on nicotine replacement therapy and other phar-
macotherapy, along with referral to smoking cessation programmes.
8.4. Advance care planning
The process of advance care planning is often inadequate in chronic respiratory diseases [47]. 
Anxiety and fear of death is well described in individuals with advanced COPD along with 
reluctance to discuss it with their treating physician [48]. The pulmonary rehabilitation pro-
gramme has been identified as an appropriate setting for discussion on advance care planning 
and end of life care [49].
The idea is to allow both patient and family a unique opportunity to communicate goals 
of treatment and preferences regarding the use of life-sustaining treatments, such as car-
diopulmonary resuscitation, mechanical ventilation, dialysis and feeding tubes, with the 
health care provider. Ideally, the discussion will facilitate better understanding of cer-
tain topics, such as the disease itself and prognosis, process of dying and end-of life care, 
advance directive documents (e.g. designating a health care proxy or enduring power of 
attorney).
8.5. Psychosocial support
Severe COPD is associated with increased risk for anxiety and depression, which can affect 
motivation levels and result in decreased participation in social activities [6, 46]. Episodes of 
dyspnoea often trigger fear and anxiety in patients with COPD and result in further anxiety 
in anticipation of repeat episodes [50]. Depression, feelings of hopelessness and an inability 
to cope are common in patients with COPD, with an approximate prevalence rate of 45% in 
patients with moderate to severe disease [51, 52]. Patients with depression have the tendency 
to withdraw from social interactions which can worsen feelings of isolation and loneliness. 
Sexual activity can be affected by depression and also the physical restrictions imposed by 
COPD itself, sexuality should be raised and discussed when necessary and appropriate coun-
selling initiated.
Screening for anxiety and depression should be included at the initial assessment in a pul-
monary rehabilitation programme. If possible interviewing and involving the caregiver is 
beneficial. Promotion of an adequate patient support system is an important component of 
pulmonary rehabilitation [53]. Psychological and social support provided within the pulmo-
nary rehabilitation setting can facilitate adjustment the physiological impact of the disease by 
Pulmonary Rehabilitation in COPD: Current Practice and Future Directions
http://dx.doi.org/10.5772/intechopen.71218
117
encouraging adaptive thoughts and behaviours. These aid patients in diminishing negative 
emotions, provides a socially supportive environment and may improve compliance with 
rehabilitation. Multidisciplinary team members with the appropriate expertise to address 
these issues are most useful and referral to appropriate professional care may be necessary.
8.6. Nutrition
Nutrition counselling and education on weight management are particularly important in 
lung disease. Up to 20–30% of normal weight individuals with COPD show a shift in body 
composition to muscle wasting and relative increased fat mass, independent of spirometric 
severity [53]. Typically, underweight status and weight loss are more prevalent in advanced 
disease and emphysematous phenotype [54], while obesity is more prevalent in mild dis-
ease [53]. Patients with COPD are at risk of obesity and muscle wastage due to limitations in 
physical activity and adverse effects of glucocorticoids given for exacerbations. For patients 
with COPD there is an association between underweight status and lean muscle loss and 
increased mortality, again independent of FEV1 [55, 56], in addition underweight patients 
report a lower HRQoL status then normal weight patients with COPD [57].
Changes in body weight or BMI do not accurately reflect all the changes in body composi-
tion that occur in patients with COPD. Body weight is made up of fat mass and fat free mass 
(FFM), fat free mass consists of water and body cell mass (organ, muscles, bone). Muscle mass 
constitutes a major part of fat free mass. The loss of FFM is characteristic of chronic lung dis-
eases such as COPD and in severe COPD low FFM and mid-thigh cross sectional area have 
been shown to be a better predictor of prognosis than BMI [58]. Patients with COPD and low 
FFM have a lower exercise tolerance and impaired respiratory muscle strength than patients 
with maintained FFM [59–61]. FFM can be estimated using skinfold anthrometry, bioimped-
ance analysis or dual energy X-ray absorptiometry (DEXA).
A comprehensive pulmonary rehabilitation programme should at a minimum include a sim-
ple nutritional screening, such as calculating patient’s body mass index or BMI. The aetiology 
of weight loss and muscle wasting in COPD is complex and a number of different physiologic 
and pharmacologic interventions have been used to stop or even reverse the process. This 
includes simple nutritional supplementation with an emphasis on adequate protein intake in 
order to stimulate protein synthesis to maintain or restore FFM. The increased energy require-
ments during activity in pulmonary rehabilitation must also be met in both underweight and 
normal weight individuals. Nutritional supplementation alone has not been successful in 
achieving significant weight gain. However, a 6 month intervention of dietary counselling 
along with nutritional supplementation resulted in significant weight gain and maintenance 
of FFM compared with control group [62].
9. Post rehabilitation assessment
9.1. Patient-centred outcomes
Patient-centred outcomes are used as outcome measures in pulmonary rehabilitation to mea-
sure the change or impact the pulmonary rehabilitation programme has had on the patient’s 
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symptoms and quality of life [6]. Outcomes used during the programme should be valid, reli-
able and sensitive to change and have descriptions of relevant change, such as the minimally 
clinical important difference, which indicate a meaningful change of the condition for better 
or for worse.
Outcome measures used are generally generic or disease specific, and should assess quality 
of life (health related quality of life, symptoms and functional impairment), depression and 
anxiety, functional status and breathlessness.
Exacerbation history should also be documented as an outcome measure. The same exercise 
test used in the pre-rehabilitation assessment (6MWT or ISWT) should also be reassessed on 
completion of the programme to assess for improvements in exercise capacity. Quality of life 
measures are used to assess symptoms, physiological functioning, functional impairment 
and health related quality of life [55, 63, 64]. At least one of these questionnaires is advised 
and may include, for example, the Chronic Respiratory Disease Questionnaire [65, 66], the St. 
Georges Respiratory Questionnaire [16], or the COPD Assessment Test [67]. As outlined previ-
ously, up to 40% of COPD patients have symptoms of depression and anxiety [68]. All patients 
should be assessed both before and after the rehabilitation programme using, for example, 
the Hospital Anxiety and Depression Scale [68, 69], and an onward referral to a mental health 
professional considered if symptoms persist significantly on completion of the programme.
Patients who are attending pulmonary rehabilitation should have the outcome of their treat-
ment in terms of dyspnoea, health status and exercise capacity measured. Objective measure-
ments of a patient’s baseline function and post-rehabilitation function, and reassessments in 
the months following completion of the rehabilitation programme allows the co-ordinator 
to assess the benefit obtained by the individual during the programme, to provide quality 
assurance for the rehabilitation services and to facilitate ongoing referrals if required. Other 
measures of outcome, such as muscle strength, nutritional status, physical activity levels and 
self-efficacy measures) may also be beneficial.
10. Unanswered questions in pulmonary rehabilitation
10.1. Where is the ideal location to carry out rehabilitation?
The ideal location to carry out rehabilitation is currently unclear. The settings for pulmo-
nary rehabilitation programmes vary; most of the research to date has involved outpatient 
programmes; however pulmonary rehabilitation programmes may also be conducted in an 
inpatient hospital or home setting. In a recent international survey involving 400 centres in 40 
countries, 85% of pulmonary rehabilitation programmes in Europe and North America were 
using an outpatient model [70]. Outpatient settings include hospital outpatient departments, 
community facilities and physiotherapy clinics.
Inpatient rehabilitation is offered in hospitals and can provide specialised rehabilitation care 
for individuals in a stable pulmonary state or after an exacerbation. It certain cases it can 
be initiated during inpatient acute care including the intensive care unit where ventilator 
limitations may limit aerobic exercise, but resistive muscle training can be well tolerated and 
is associated with improved 6-minute walk distance and muscle strength [6, 71]. Potential 
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disadvantages with inpatient rehabilitation include higher costs and lack of coverage by 
health insurance in certain countries.
Home based rehabilitation is an alternative model, which involves transferring the site of 
exercise training to the home. This could make the course more convenient and broaden the 
availability of the service. There is increasing evidence comparing home- and hospital-based 
programmes, including a recent large randomised equivalence study of home vs. outpatient 
rehabilitation. This demonstrated that important outcomes such as functional exercise capac-
ity and health related quality of life were equivalent between both groups [72]. Fernandez and 
colleagues demonstrated that a home-based programme was safe and effective in a group of 
50 patients with severe COPD on long-term supplemental oxygen [73]. There has been little 
uptake in clinical practice, with less than 5% of centres worldwide providing home based 
rehabilitation [70]. This is likely a result of limitations in some of the current studies, with 
many being underpowered or failing to provide all of the essential components of pulmonary 
rehabilitation.
The American Thoracic Society (ATS)/European Respiratory Society (ERS) Policy Statement 
on Pulmonary Rehabilitation identified the need to increase accessibility of pulmonary reha-
bilitation as a key priority, which includes investigating novel PR programme models that 
are more accessible and acceptable to patients [74]. Thus, when choosing a rehabilitation set-
ting characteristics of both a particular healthcare system or setting and the patient as an 
individual need to be considered. Factors such as transportation, availability of various pro-
gramme settings as described above and in certain countries, payment considerations and 
health insurance need also to be considered. In relation to patient specific factors, the severity 
of their disease is important, as is the haemodynamic stability of a patient often in the con-
text of recent exacerbation, co-morbidities and extent of disability if any. These factors can 
influence the most appropriate setting and level of supervision a patient needs enrolling in a 
pulmonary rehabilitation programme.
10.2. What are the barriers to the uptake of pulmonary rehabilitation?
One key goal of pulmonary rehabilitation is ongoing lifestyle modification to encourage 
patients to undertake a more active lifestyle in the future. Despite the extensive evidence 
for its benefits, pulmonary rehabilitation is delivered to fewer than 10% with those with 
COPD who would benefit [52]. Accessibility is a major factor particularly in rural settings 
where programmes are not available or appropriate infrastructure to provide them does not 
exist. However, it has also been shown in metropolitan areas that up to 50% of those who are 
referred will never attend and of those who do present, up to a third will not complete the 
programme [75].
A systematic review in 2011 was carried out to identify barriers to uptake and factors affect-
ing pulmonary rehabilitation adherence. The factors that influence whether people choose to 
attend their initial appointment can be different to the factors that influence programme com-
pletion [75]. A number of barriers to enrolment following referral were identified, including:
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• Disruption to established routine, varying from concerns over missing social activities to 
work commitments or carer demands such as caring for other family members.
• Travel, transport and location, including distance to travel, available transportation or in-
ability to travel independently.
• Influence of the referring physician – some patients declined to attend following referral by 
a doctor they did not know or if the perceived that their doctor did not think the rehabilita-
tion programme would benefit them.
• Lack of perceived benefit, as some studies report patients perceiving their disease to be too 
severe to gain improvement or that the programme lacks guaranteed benefits.
• Inconvenient timing of the programme – patient preference on timing of rehabilitation ses-
sions can vary between morning and afternoon, and given the limited capacity and avail-
ability not everyone’s preference can be accommodated.
The definition of programme non-adherence varies in the literature from declining to par-
ticipate in the programme to attending at least one session. A non-adherence rate ranging 
from 10 to 32% has been described and varies considerably from study to study [75]. Factors 
associated with non-adherence include illness and co-morbidities, travel, transportation, lack 
of perceived benefits, smoking, depressive symptoms and lack of support [27, 76]. Cigarette 
smoking at enrolment was the sole independent risk factor for non-completion of pulmonary 
rehabilitation, in the systematic review described above [75]. This highlights the importance 
of the educational component and facilitating behaviour change including programmes for 
strategies for smoking cessation.
10.3. How can the benefits of pulmonary rehabilitation be maintained?
Given the nature of COPD as a progressive chronic disease, it frequently results in a progres-
sive loss of function over time. It is therefore reasonable that any benefits obtained from an 
initial programme are likely to regress over time [3]. The benefits of an initial pulmonary reha-
bilitation programme have been shown to persist to some degree for at least 12 months, with 
quality of life maintained better than the increased exercise capacity. Developing strategies 
to extend the effects of the rehabilitation programme is extremely important. The benefits of 
ongoing supervised maintenance exercise programmes beyond the completion of the initial 
cycle remains uncertain [6].
A repeat programme in those whose condition has deteriorated more than 1 year since com-
pleting the programme should be considered, and an earlier repeat programme may be war-
ranted in those patients with a profound physiological decline within the initial 12 months 
of completing the programme. The benefits of a repeat programme of a patient who failed to 
benefit from the original programme are questionable. Ongoing exercise upon completing 
the programme should be encouraged in all patients, and opportunities for exercise upon 
completion of the programme should be provided to all patients.
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Implementation of a home exercise programme at least twice a week at an early stage dur-
ing the rehabilitation programme encourages the participant to exercise independently dur-
ing the programme, but also improves adherence to regular exercise once the programme 
has been completed. Written material with an individualised description and prescription 
of each exercise, resembling those undertaken in the supervised classes should be provided 
to each participant. The programme coordinator should monitor the patients home exercise 
diary throughout the programme, and any barriers to exercise that the patient is experiencing 
should be addressed. Precautions and advice on exercise should also be addressed [20].
On completion of the programme, patients should be provided with a written, individual-
ised, structured plan for ongoing exercise maintenance to encourage ongoing exercise. It 
should include aerobic and strength exercises, and information on local exercise amenities. 
Patients should be asked to reflect on the effect the programme has had on their daily physi-
cal activity and on their symptoms. Strategies to maintain their improvements and adher-
ence to an ongoing exercise programme should be discussed. Regular assessments following 
completion of the initial programme can assist in maintaining the gains achieved during the 
programme [22].
10.4. Is there a role for new technology?
Pulmonary rehabilitation has rapidly established itself as a cornerstone in the comprehensive 
management of patients with COPD. As previously stated, a recent joint policy statement by 
the ATS and ERS has identified improved access and delivery of pulmonary rehabilitation 
to suitable patients as a priority in need of further research and development. As popularity 
and lack of capacity increase demand, other settings for effective rehabilitation will need to 
be found. These new settings would ideally maintain the quality and effectiveness of conven-
tional programmes but be more convenient to patients [6].
New technology may play a part in improving services by telemonitoring or provision of 
remote rehabilitation to inaccessible regions. Telemedicine is the use of telecommunication 
and information technology to provide clinical health care from a distance. Telerehabilitation 
is the delivery of rehabilitation services over telecommunication networks and the internet, 
allowing point-to-point video conferencing between a central control unit and a patient at 
home. This is a promising way of delivering health services to individuals who may live in 
isolated areas without adequate access to transportation or have a level of disability which 
limits their ability to travel. A study carried out in 2008 used mobile phone based systems to 
remotely monitor an endurance exercise programme at home [77]. This programme provided 
a music component with an appropriate tempo to facilitate the correct intensity of training; 
adherence could also be monitored and appropriate feedback and support delivered. The 
study demonstrated good compliance and significant improvement, and was also associated 
with fewer exacerbations and hospitalisations [78].
There has also been evidence to support the delivery of a pulmonary rehabilitation pro-
gramme from a large expert centre to smaller regional centres via videoconferencing [78]. In a 
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controlled trial, there were equivalent outcomes for exercise capacity and quality of life. One 
other small trial in individuals with moderate to severe COPD, who had completed at least 
12 sessions of outpatient pulmonary rehabilitation, found that telemonitoring by health care 
professionals reduced primary care contacts for respiratory issues compared with usual care 
[79]. Neither demonstrated any differences between groups and hospital admissions, days in 
hospital or contact with COPD nurse specialists in the community.
Education, psychosocial support and counselling are components of a pulmonary rehabilita-
tion programme which are critical to its success. A study in 2006 demonstrated that the com-
bination of exercise counselling, stimulation of lifestyle change or adaption and the use of a 
pedometer is feasible and may improve outcome and maintenance of rehabilitation results 
[80]. Results of a systematic review comparing home telemonitoring with usual care showed 
that home telehealth (home telemonitoring and telephone support) decreased rates of hospi-
talisation and emergency department visits, whereas findings for hospital days varied between 
studies. There is a great deal of variability between studies in terms of interventions and 
approach [81].
11. Conclusion
Pulmonary rehabilitation is one of the most cost-effective therapies for individuals with chronic 
respiratory disease. Despite this, many programmes are not funded adequately due to a lack of 
knowledge and awareness of the benefits of pulmonary rehabilitation. Healthcare profession-
als in clinical practice are often not familiar with the benefits, science and process of pulmo-
nary rehabilitation, and therefore do not offer it to suitable patients. The need for standardised 
formal training in pulmonary rehabilitation is clear. Interestingly, even when referred, uptake 
of pulmonary rehabilitation by suitable patients remains poor. This may be due to a perception 
of pulmonary rehabilitation as being difficult or frightening. Therefore, equally important is 
patient education regarding the proven benefits of pulmonary rehabilitation and the processes 
by which those benefits are attained. Given that pulmonary rehabilitation is an evidence-
based, widely-accepted gold standard treatment for many respiratory patients, the disparity 
in access and availability results in unacceptable inequality of healthcare [82].
Author details
Michelle Casey†, Amy Mulkerns†, Cliona O’Donnell† and Tim McDonnell*
*Address all correspondence to: timothymcdonnell@icloud.com
Department of Respiratory Medicine, St. Michaels Hospital and St. Vincent’s University 
Hospital, Dublin, Ireland
†These authors contributed equally




[1] McCarthy B, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. 
Cochrane Database of Systematic Reviews. 2015 Feb 23;(2):CD003793. DOI: 10.1002/ 
14651858.CD003793.pub3
[2] Puhan M, et al. Pulmonary rehabilitation following exacerbations of chronic obstructive 
pulmonary disease. Cochrane Database of Systematic Reviews. 2009 Jan 21;(1):CD005305. 
DOI: 10.1002/14651858.CD005305.pub2
[3] Bolton CE, et al. British Thoracic Society guideline on pulmonary rehabilitation in adults. 
Thorax. 2013;68(Suppl 2):ii1-ii30
[4] Casaburi R. A brief history of pulmonary rehabilitation. Respiratory Care. 2008;53(9): 
1185-1189
[5] Maltais F, et al. Skeletal muscle adaptation to endurancetraining in patients with chronic 
obstructive pulmonary disease. American Journal of Respiratory and Critical Care 
Medicine. 1996;154(2 Pt 1):442-447
[6] Spruit MA, et al. An official American Thoracic Society/European Respiratory Society 
statement: Key concepts and advances in pulmonary rehabilitation. American Journal of 
Respiratory and Critical Care Medicine. 2013;188(8):e13-e64
[7] Bernard S, et al. Aerobic and strength training in patients with chronic obstructive 
pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 
1999;159(3):896-901
[8] Griffiths TL, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilita-
tion: A randomised controlled trial. Lancet. 2000;355(9201):362-368
[9] Ries AL, et al. Effects of pulmonary rehabilitation on physiologic and psychosocial 
outcomes in patients with chronic obstructive pulmonary disease. Annals of Internal 
Medicine. 1995;122(11):823-832
[10] Franssen FM, et al. Effects of whole-body exercise training on body composition and 
functional capacity in normal-weight patients with COPD. Chest. 2004;125(6):2021-2028
[11] Spruit MA, et al. Resistance versus endurance training in patients with COPD and 
peripheral muscle weakness. The European Respiratory Journal. 2002;19(6):1072-1078
[12] Swallow EB, et al. Quadriceps strength predicts mortality in patients with moderate to 
severe chronic obstructive pulmonary disease. Thorax. 2007;62(2):115-120
[13] Ries AL, et al. Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based clinical 
practice guidelines. Chest. 2007;131(5 Suppl):4s-42s
[14] Casaburi R, et al. Reductions in exercise lactic acidosis and ventilation as a result of 
exercise training in patients with obstructive lung disease. The American Review of 
Respiratory Disease. 1991;143(1):9-18
COPD - An Update in Pathogenesis and Clinical Management124
[15] Polkey MI, Rabe KF. Chicken or egg: Physical activity in COPD revisited. European 
Respiratory Journal. 2009;33(2):227-229
[16] Jones PW, et al. A self-complete measure of health status for chronic airflow limitation: 
The St. George's respiratory questionnaire. American Review of Respiratory Disease. 
1992;145(6):1321-1327
[17] Kirshner B, Guyatt G. A methodological framework for assessing health indices. Journal 
of Chronic Diseases. 1985;38(1):27-36
[18] D-C Man W, et al. Community pulmonary rehabilitation after hospitalisation for acute 
exacerbations of chronic obstructive pulmonary disease: Randomised controlled study. 
British Medical Journal. 2004;329(7476):1209
[19] Ries AL, et al. The effects of pulmonary rehabilitation in the national emphysema treat-
ment trial. Chest. 2005;128(6):3799-3809
[20] Garvey C, et al. Pulmonary rehabilitation exercise prescription in chronic obstruc-
tive pulmonary disease: Review of selected guidelines: An official statement from The 
American Association of Cardiovascular and Pulmonary Rehabilitation. Journal of 
Cardiopulmonary Rehabilitation and Prevention. 2016;36(2):75-83
[21] Medicine, A.C.o.S. ACSM's Guidelines for Exercise Testing and Prescription. Philadelphia 
PA: Lippincott Williams & Wilkins; 2013
[22] Jenkins S, Hill K, Cecins NM. State of the art: How to set up a pulmonary rehabilitation 
program. Respirology. 2010;15(8):1157-1173
[23] Nici L, et al. American Thoracic Society/European Respiratory Society statement on 
pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine. 
2006;173(12):1390-1413
[24] Trappenburg JC, et al. Psychosocial conditions do not affect short-term outcome of 
multidisciplinary rehabilitation in chronic obstructive pulmonary disease. Archives of 
Physical Medicine and Rehabilitation. 2005;86(9):1788-1792
[25] Haave E, Skumlien S, Hyland ME. Gender considerations in pulmonary rehabilitation. 
Journal of Cardiopulmonary Rehabilitation and Prevention. 2008;28(3):215-219
[26] Di Meo F, et al. Age does not hamper the response to pulmonary rehabilitation of COPD 
patients. Age and Ageing. 2008;37(5):530-535
[27] Garrod R, et al. Predictors of success and failure in pulmonary rehabilitation. European 
Respiratory Journal. 2006;27(4):788
[28] Evans RA, et al. Pulmonary rehabilitation is successful for COPD irrespective of MRC 
dyspnoea grade. Respiratory Medicine. 2009;103(7):1070-1075
[29] Sabit R, et al. Predictors of poor attendance at an outpatient pulmonary rehabilitation 
programme. Respiratory Medicine. 2008;102(6):819-824
Pulmonary Rehabilitation in COPD: Current Practice and Future Directions
http://dx.doi.org/10.5772/intechopen.71218
125
[30] Berry MJ, et al. Exercise rehabilitation and chronic obstructive pulmonary disease stage. 
American Journal of Respiratory and Critical Care Medicine. 1999;160(4):1248-1253
[31] Chavannes N, et al. Effects of physical activity in mild to moderate COPD: A systematic 
review. The British Journal of General Practice. 2002;52(480):574-578
[32] Spruit MA, et al. Effects of moderate-to-high intensity resistance training in patients 
with chronic heart failure. Heart. 2009;95(17):1399-1408
[33] Tan KH, De Cossart L, Edwards PR. Exercise training and peripheral vascular disease. 
The British Journal of Surgery. 2000;87(5):553-562
[34] Bennell KL, Hinman RS. A review of the clinical evidence for exercise in osteoarthritis of 
the hip and knee. Journal of Science and Medicine in Sport. 2011;14(1):4-9
[35] O'Gorman DJ, Krook A. Exercise and the treatment of diabetes and obesity. Medical 
Clinics of North America. 2011;95(5):953-969
[36] Rees K, et al. Exercise based rehabilitation for heart failure. Cochrane Database of 
Systematic Reviews. 2010 Apr 14;(4):CD003331. DOI: 10.1002/14651858.CD003331.pub3
[37] Redelmeier DA, et al. Interpreting small differences in functional status: The six minute 
walk test in chronic lung disease patients. American Journal of Respiratory and Critical 
Care Medicine. 1997;155(4):1278-1282
[38] Munro PE, et al. Pulmonary rehabilitation following lung transplantation. Transplantation 
Proceedings. 2009;41(1):292-295
[39] Make B. Collaborative self-management strategies for patients with respiratory disease. 
Respiratory Care. 1994;39(5):566-579 discussion 579-83
[40] Bourbeau J, Nault D, Dang-Tan T. Self-management and behaviour modification in 
COPD. Patient Education and Counseling. 2004;52(3):271-277
[41] Rice KL, et al. Disease management program for chronic obstructive pulmonary dis-
ease: A randomized controlled trial. American Journal of Respiratory and Critical Care 
Medicine. 2010;182(7):890-896
[42] Bischoff EW, et al. Effects of written action plan adherence on COPD exacerbation recov-
ery. Thorax. 2011;66(1):26-31
[43] Gosselink R. Breathing techniques in patients with chronic obstructive pulmonary dis-
ease (COPD). Chronic Respiratory Disease. 2004;1(3):163-172
[44] Lareau S, Larson JL. Ineffective breathing pattern related to airflow limitation. The 
Nursing Clinics of North America. 1987;22(1):179-191
[45] Jones AP, Rowe BH. Bronchopulmonary hygiene physical therapy for chronic obstruc-
tive pulmonary disease and bronchiectasis. Cochrane Database of Systematic Reviews. 
2000;(2):CD000045
[46] From the Global Strategy for the Diagnosis, Management and Prevention of COPD, 
Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. www.goldcopd.
org (cited July 2017)
COPD - An Update in Pathogenesis and Clinical Management126
[47] Spruit MA, et al. Rehabilitation and palliative care in lung fibrosis. Respirology. 
2009;14(6):781-787
[48] Janssen DJA, et al. A call for high-quality advance care planning in outpatients with 
severe COPD or chronic heart failure. Chest. 2011;139(5):1081-1088
[49] Heffner JE. Advance care planning in chronic obstructive pulmonary disease: Barriers 
and opportunities. Current Opinion in Pulmonary Medicine. 2011;17(2):103-109
[50] Heim E, Blaser A, Waidelich E. Dyspnea: Psychophysiologic relationships. Psychosomatic 
Medicine. 1972;34(5):405-423
[51] Mills TL. Comorbid depressive symptomatology: Isolating the effects of chronic medi-
cal conditions on self-reported depressive symptoms among community-dwelling older 
adults. Social Science & Medicine. 2001;53(5):569-578
[52] Yohannes AM, Connolly MJ. Pulmonary rehabilitation programmes in the UK: A 
national representative survey. Clinical Rehabilitation. 2004;18(4):444-449
[53] Emery CF, et al. Psychological and cognitive outcomes of a randomized trial of exer-
cise among patients with chronic obstructive pulmonary disease. Health Psychology. 
1998;17(3):232-240
[54] Engelen MP, et al. Different patterns of chronic tissue wasting among patients with 
chronic obstructive pulmonary disease. Clinical Nutrition. 1999;18(5):275-280
[55] Schols AM, et al. Weight loss is a reversible factor in the prognosis of chronic obstruc-
tive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 
1998;157(6 Pt 1):1791-1797
[56] Prescott E, et al. Prognostic value of weight change in chronic obstructive pulmonary 
disease: Results from the Copenhagen City heart study. The European Respiratory 
Journal. 2002;20(3):539-544
[57] Shoup R, et al. Body composition and health-related quality of life in patients with 
obstructive airways disease. European Respiratory Journal. 1997;10(7):1576-1580
[58] Marquis K, et al. Midthigh muscle cross-sectional area is a better predictor of mortality 
than body mass index in patients with chronic obstructive pulmonary disease. American 
Journal of Respiratory and Critical Care Medicine. 2002;166(6):809-813
[59] Mostert R, et al. Tissue depletion and health related quality of life in patients with 
chronic obstructive pulmonary disease. Respiratory Medicine. 2000;94(9):859-867
[60] Kobayashi A, et al. The relation of fat-free mass to maximum exercise performance in 
patients with chronic obstructive pulmonary disease. Lung. 2000;178(2):119-127
[61] Nishimura Y, et al. Relationship between respiratory muscle strength and lean body 
mass in men with COPD. Chest. 1995;107(5):1232-1236
[62] Weekes CE, Emery PW, Elia M. Dietary counselling and food fortification in stable 
COPD: A randomised trial. Thorax. 2009;64(4):326-331
Pulmonary Rehabilitation in COPD: Current Practice and Future Directions
http://dx.doi.org/10.5772/intechopen.71218
127
[63] Taillefer M-C, et al. Health-related quality of life models: Systematic review of the litera-
ture. Social Indicators Research. 2003;64(2):293-323
[64] Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A 
conceptual model of patient outcomes. Journal of the American Medical Association. 
1995;273(1):59-65
[65] Guyatt GH, et al. A measure of quality of life for clinical trials in chronic lung disease. 
Thorax. 1987;42(10):773-778
[66] Williams JEA, et al. Health status measurement: Sensitivity of the self-reported chronic 
respiratory questionnaire (CRQ-SR) in pulmonary rehabilitation. Thorax. 2003;58(6):515
[67] Jones PW, et al. Development and first validation of the COPD assessment test. European 
Respiratory Journal. 2009;34(3):648
[68] Coventry PA. Does pulmonary rehabilitation reduce anxiety and depression in chronic 
obstructive pulmonary disease? Current Opinion in Pulmonary Medicine. 2009;15(2): 
143-149
[69] Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica 
Scandinavica. 1983;67(6):361-370
[70] Spruit MA, et al. Differences in content and organisational aspects of pulmonary reha-
bilitation programmes. European Respiratory Journal. 2014;43(5):1326-1337
[71] Troosters T, et al. Resistance training prevents deterioration in quadriceps muscle func-
tion during acute exacerbations of chronic obstructive pulmonary disease. American 
Journal of Respiratory and Critical Care Medicine. 2010;181(10):1072-1077
[72] Holland AE, et al. Home-based rehabilitation for COPD using minimal resources: A ran-
domised, controlled equivalence trial. Thorax. 2016
[73] Fernandez AM, et al. Home-based pulmonary rehabilitation in very severe COPD: 
Is it safe and useful? Journal of Cardiopulmonary Rehabilitation and Prevention. 
2009;29(5):325-331
[74] Rochester CL. An official American Thoracic Society/European Respiratory Society 
 policy statement: Enhancing implementation, use, and delivery of pulmonary rehabili-
tation. Am J Respir Crit Care Med. 2015;192(11):1373-1386
[75] Keating A, Lee A, Holland AE. What prevents people with chronic obstructive pulmo-
nary disease from attending pulmonary rehabilitation? A systematic review. Chronic 
Respiratory Disease. 2011;8(2):89-99
[76] Hogg L, et al. Effectiveness, attendance, and completion of an integrated, system-wide 
pulmonary rehabilitation service for COPD: Prospective observational study. Chronic 
Obstructive Pulmonary Disease. 2012;9(5):546-554
[77] Liu WT, et al. Efficacy of a cell phone-based exercise programme for COPD. The 
European Respiratory Journal. 2008;32(3):651-659
COPD - An Update in Pathogenesis and Clinical Management128
[78] Stickland M, et al. Using Telehealth technology to deliver pulmonary rehabilitation 
in chronic obstructive pulmonary disease patients. Canadian Respiratory Journal. 
2011;18(4):216-220
[79] Lewis KE, et al. Does home telemonitoring after pulmonary rehabilitation reduce health-
care use in optimized COPD? A pilot randomized trial. Chronic Obstructive Pulmonary 
Disease. 2010;7(1):44-50
[80] de Blok BM, et al. The effects of a lifestyle physical activity counseling program with 
feedback of a pedometer during pulmonary rehabilitation in patients with COPD: A 
pilot study. Patient Education and Counseling. 2006;61(1):48-55
[81] Polisena J, et al. Home telehealth for chronic obstructive pulmonary disease: A system-
atic review and meta-analysis. Journal of Telemedicine and Telecare. 2010;16(3):120-127
[82] Vogiatzis I, et al. American Journal of Respiratory and Critical Care Medicine
Pulmonary Rehabilitation in COPD: Current Practice and Future Directions
http://dx.doi.org/10.5772/intechopen.71218
129

